Market Cap
$501.9M
PROK
PROKIDNEY CORP.
$1.72 ▲ +0.58%
Prev close $1.71Market cap$501.9M
12-mo target$6.25 (+263.4%)
11 New Institutional Positions7 Institutional Exits Biotech & Drug Discovery
Snapshot
The big-picture read on PROK right now — valuation, ownership and activity at a glance.
Cap Size
Small Cap
Inst. Holders
50 funds
Inst. Value
$57.2M
Inst. Activity
11 buys / 7 sells
Insider Activity
$0.00 buy / $1.1M sell
Insider Net $
-$1.1M
SEC Reports
5
Press Releases
1
Price chart 30d -10.4%
Daily candles (open–high–low–close) with volume. Green = up day, red = down day.
No data for this timeframe.
Vol
Recent activity
The latest filings, insider trades, analyst actions, press and options flow — newest first.
Oct 2, 2026 other
ProKidney Announces Eight Abstracts Selected for Presentation at the American Society of Nephrology’s Kidney Week 2026
WINSTON-SALEM, N.C., Oct. 02, 2026 (GLOBE NEWSWIRE) -- ProKidney Corp. (Nasdaq: PROK) (“ProKidney” o
Aug 20, 2026 Insider
Pereira Brian JG sold 27,052 shares
Director @ $1.42 ($38.4K)
Aug 20, 2026 Insider
Pereira Brian JG sold 222,948 shares
Director @ $1.42 ($316.6K)
Aug 19, 2026 Insider
Aug 11, 2026 SEC Pereira Brian JG sold 27,051 shares
Director @ $1.44 ($39.0K)
ProKidney reported Q2 2026 results with no revenue or EPS surprises vs consensus, as the company remains a pre-commercia
8-K — Impact 5/10
ProKidney reported Q2 2026 financial results with no revenue or EPS guidance to analyze, as the company is pre-commercia
PRESS-RELEASE — Impact 5/10
Jun 30, 2026 Inst.
BlackRock, Inc. — DOUBLED
5,197,227 shares ($10.6M)
Jun 30, 2026 Inst.
GEODE CAPITAL MANAGEMENT, LLC — ADD
2,390,147 shares ($4.9M)
Analyst ratings buy % +0.0%
How Wall Street rates the stock today, and the latest firm-by-firm actions.
Recent analyst actions
| Date | Firm | Action | Rating | Firm rating |
|---|---|---|---|---|
| May 18, 2026 | HC Wainwright & Co. | REITERATE | Buy | 43% |
Monthly consensus history
| Period | Str. Buy | Buy | Hold | Sell | Str. Sell | Buy % | Distribution |
|---|---|---|---|---|---|---|---|
| Sep 1, 2026 | 5 | 5 | 4 | 1 | 0 | 67% | |
| Aug 1, 2026 | 5 | 5 | 4 | 1 | 0 | 67% | |
| Jul 1, 2026 | 5 | 5 | 4 | 1 | 0 | 67% | |
| Jun 1, 2026 | 5 | 5 | 4 | 1 | 0 | 67% | |
| May 1, 2026 | 5 | 5 | 4 | 1 | 0 | 67% | |
| Apr 1, 2026 | 5 | 5 | 4 | 1 | 0 | 67% | |
| Mar 1, 2026 | 5 | 5 | 4 | 1 | 0 | 67% | |
| Feb 1, 2026 | 5 | 5 | 4 | 1 | 0 | 67% |
Price targets
Where 6 covering analysts think PROK trades over the next 12 months.
$6.25 +263.4% upside Strong Buy
Current$1.72 Low$1.00 Median$5.75 High$12.00 6 analysts
$1.00$12.00
Analyst rating None as of Oct 2, 2026
Reports & filings
AI-scored summaries of recent SEC filings and press releases, with sentiment and impact.
5 SEC filing reports analyzed · 0 bullish, 0 bearish, 0 mixed, 5 neutral · avg impact 4.2/10.Plus 1 press releases.
NEUTRAL8-K5/10
ProKidney reported Q2 2026 results with no revenue or EPS surprises vs consensus, as the company rem
Aug 11, 2026
NEUTRALPRESS-RELEASE5/10
ProKidney reported Q2 2026 financial results with no revenue or EPS guidance to analyze, as the comp
Aug 10, 2026
NEUTRAL8-K4/10
ProKidney reported Q1 2026 financial results that were in line with consensus, with a net loss of $2
May 15, 2026
NEUTRALPRESS-RELEASE5/10
ProKidney reported Q1 2026 EPS of -$0.14, essentially in line with the -$0.14 consensus (a 1.8% miss
May 15, 2026
Upcoming & catalyst events
Scheduled dates plus disclosed catalysts — earnings, dividends, enforcement, FDA and clinical-trial events. Colored dot = impact.
Oct 2, 2026
other
ProKidney Announces Eight Abstracts Selected for Presentation at the American Society of Nephrology’s Kidney Week 2026
WINSTON-SALEM, N.C., Oct. 02, 2026 (GLOBE NEWSWIRE) -- ProKidney Corp. (Nasdaq: PROK) (“ProKidney” or the “Company”), a leading late clinical-stage ce
Sep 28, 2026
short_volume
Short Volume: PROK — 63.7% short (0.7M / 1.0M)
Short: 650,611 | Exempt: 4 | TRF Vol: 1,021,729 | Short Ratio: 63.7% | Off-exchange volume (dark pool + OTC)
Sep 24, 2026
short_volume
Short Volume: PROK — 71.6% short (0.5M / 0.7M)
Short: 480,154 | Exempt: 0 | TRF Vol: 670,674 | Short Ratio: 71.6% | Off-exchange volume (dark pool + OTC)
Sep 23, 2026
short_volume
Short Volume: PROK — 87.9% short (0.4M / 0.5M)
Short: 443,534 | Exempt: 0 | TRF Vol: 504,801 | Short Ratio: 87.9% | Off-exchange volume (dark pool + OTC)
Sep 21, 2026
short_volume
Short Volume: PROK — 77.9% short (0.6M / 0.7M)
Short: 577,341 | Exempt: 1,047 | TRF Vol: 741,407 | Short Ratio: 77.9% | Off-exchange volume (dark pool + OTC)
Earnings estimates
Forecast earnings per share and revenue by period — and whether estimates are rising.
| Period | EPS Est. | Range | Growth | 30d Rev | Up/Dn | Revenue | # |
|---|---|---|---|---|---|---|---|
| Current Q | $-0.14 | $-0.17–$-0.12 | -16.5% | +1.1% | 1↑ 2↓ | $0.0B | 5 |
| Next Q | $-0.14 | $-0.19–$-0.11 | 1.4% | +2.8% | 3↑ 2↓ | $0.0B | 5 |
| Current FY | $-0.56 | $-0.66–$-0.50 | -8.1% | -4.4% | 0↑ 5↓ | $0.0B | 5 |
| Next FY | $-0.59 | $-0.78–$-0.42 | -4.3% | -1.8% | 1↑ 3↓ | $0.0B | 5 |
Current-quarter EPS estimate — revision history
| When | EPS estimate | Change vs now |
|---|---|---|
| Current | $-0.140 | — |
| 7d ago | $-0.141 | +0.002 |
| 30d ago | $-0.141 | +0.002 |
| 60d ago | $-0.141 | +0.002 |
| 90d ago | $-0.154 | +0.014 |
Institutional ownership
Which big funds own PROK (from quarterly 13F filings) and who is adding or trimming.
50 institutional holders with $57.2M total value (28,034,347 shares) as of 2026-Q2. Top holders: MORGAN, BlackRock,, GEODE. Net buying activity: 11 institutions added/increased vs 7 reduced.
Top holders — 2026-Q2
| Fund | Shares | Value | % Tracked | Last move |
|---|---|---|---|---|
| MORGAN STANLEY | 9,854,178 | $20.1M | 35.2% | ADD +30.7% |
| BlackRock, Inc. | 5,197,227 | $10.6M | 18.5% | DOUBLED +274.7% |
| GEODE CAPITAL MANAGEMENT, LLC | 2,390,147 | $4.9M | 8.5% | ADD +94.3% |
| VANGUARD CAPITAL MANAGEMENT LLC | 1,175,257 | $2.4M | 4.2% | — |
| RENAISSANCE TECHNOLOGIES LLC | 1,099,400 | $2.2M | 3.9% | ADD +39.6% |
| MILLENNIUM MANAGEMENT LLC | 1,054,705 | $2.2M | 3.8% | TRIM -53.6% |
| STATE STREET CORP | 1,045,945 | $2.1M | 3.7% | ADD +87.8% |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 781,729 | $1.6M | 2.8% | — |
| UBS Group AG | 671,447 | $1.4M | 2.4% | DOUBLED +100.7% |
| NORTHERN TRUST CORP | 664,827 | $1.4M | 2.4% | DOUBLED +175.2% |
Recent position changes
| Fund | Action | Prev | Current | Change | Value |
|---|---|---|---|---|---|
| BlackRock, Inc. | DOUBLED | 1,387,116 | 5,197,227 | +274.7% | $10.6M |
| GEODE CAPITAL MANAGEMENT, LLC | ADD | 1,230,409 | 2,390,147 | +94.3% | $4.9M |
| MILLENNIUM MANAGEMENT LLC | TRIM | 2,271,577 | 1,054,705 | -53.6% | $2.2M |
| STATE STREET CORP | ADD | 556,845 | 1,045,945 | +87.8% | $2.1M |
| UBS Group AG | DOUBLED | 334,546 | 671,447 | +100.7% | $1.4M |
| NORTHERN TRUST CORP | DOUBLED | 241,580 | 664,827 | +175.2% | $1.4M |
| BANK OF AMERICA CORP /DE/ | TRIM | 753,412 | 545,158 | -27.6% | $1.1M |
| GOLDMAN SACHS GROUP INC | TRIM | 421,902 | 203,006 | -51.9% | $414.1K |
| Bank of New York Mellon Corp | DOUBLED | 11,192 | 176,657 | +1478.4% | $360.4K |
| Squarepoint Ops LLC | TRIM | 211,107 | 111,763 | -47.1% | $228.0K |
Insider activity
Buying and selling by company executives and directors (SEC Form 4).
13 insiders, 30 transactions. Net -$1.1M — $0.00 bought, $1.1M sold.
| Date | Insider | Title | Type | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Aug 20, 2026 | Pereira Brian JG | Director | SELL | 27,052 | $1.42 | $38.4K |
| Aug 20, 2026 | Pereira Brian JG | Director | SELL | 222,948 | $1.42 | $316.6K |
| Aug 19, 2026 | Pereira Brian JG | Director | SELL | 27,051 | $1.44 | $39.0K |
| Aug 19, 2026 | Pereira Brian JG | Director | SELL | 222,949 | $1.44 | $321.2K |
| Aug 18, 2026 | Pereira Brian JG | Director | SELL | 27,826 | $1.37 | $38.2K |
| Aug 18, 2026 | Pereira Brian JG | Director | SELL | 229,338 | $1.37 | $314.5K |
| Aug 4, 2026 | Pereira Brian JG | Director | CONVERT | 81,929 | — | — |
| Aug 4, 2026 | Pereira Brian JG | Director | CONVERT | 81,929 | — | — |
| Aug 4, 2026 | Pereira Brian JG | Director | CONVERT | 675,235 | — | — |
| Aug 4, 2026 | Pereira Brian JG | Director | CONVERT | 675,235 | — | — |
Short interest & halts
FINRA semi-monthly short positions, Reg SHO threshold status, and recent trading halts for PROK.
Shares short
21,445,366
Settlement Sep 15, 2026
Change vs prior
+3.4%
Semi-monthly cycle
Days to cover
19.0
At avg daily volume
Of shares outstanding
≈7.1%
Estimate — not % of float
All PROK filing & press-release reports (6)
- 8-K reportAug 11, 2026
- PRESS-RELEASE reportAug 10, 2026
- 8-K reportMay 15, 2026
- PRESS-RELEASE reportMay 15, 2026
- DEFA14A reportApr 17, 2026
- PRESS-RELEASE reportMar 18, 2026